Senzime AB (SE0002478776)

Overview

Senzime AB (publ) stands out as an innovative medical device company with a strong focus on developing, manufacturing, and marketing advanced patient monitoring systems. The company’s reach extends across Europe and the United States, serving the medical community by offering cutting-edge solutions aimed at enhancing patient care. Established in 1999 and based in Uppsala, Sweden, Senzime AB has carved a niche in the medical device industry through its robust product lineup, including the renowned TetraGraph system. A notable aspect of Senzime AB’s strategic operations includes a licensing and connectivity agreement with Masimo, underlining its commitment to integrate and streamline patient monitoring technologies with existing healthcare infrastructures.

Products and Services

• TetraGraph - A quantitative neuromuscular transmission monitor designed to assess muscle function and neuromuscular block, providing real-time, precise data crucial for patient assessment during and after surgery.
• TetraSens - Sensors specifically developed to measure muscle response to stimuli, thereby complementing the TetraGraph system's accuracy and reliability in neuromuscular monitoring.
• TetraSens Pediatric - A specialized version of TetraSens designed for pediatric patients, offering tailored decision support for this sensitive demographic.
• TetraConnect - A data management portal that facilitates the access, viewing, and exportation of data records from the TetraGraph monitor in various formats such as PDF and Excel, enhancing the efficiency of patient data management.
• TetraGraph Device Connectivity - A feature that enables seamless data transfer from the TetraGraph Monitor to patient monitoring systems, thus integrating neuromuscular monitoring data into broader patient care protocols.
• ExSpiron 2Xi - A non-invasive respiratory volume monitor that offers continuous, real-time monitoring of patients' respiratory status, aiding in the detection and prevention of respiratory complications.
• TetraGraph Philips Interface - An interface that facilitates the transmission of neuromuscular monitoring parameters from the TetraGraph system to Philips patient monitors, integrating essential monitoring data into a centralised system for enhanced patient oversight.
• CliniSenz Analyzer - Targets the need for postoperative and continuous patient monitoring in hospital settings, offering a sophisticated solution for real-time patient status assessment.
• OnZurf Probe - A sterile single-use product leveraging micro-dialysis technology for continuous sampling from gastrointestinal organs, such as the esophagus, stomach, and liver, providing valuable insights into the patient’s internal chemistry and organ function.
• TetraGraph Smart Cable Module - A collaboration between Senzime AB and Masimo resulting in a module that connects directly to Masimo's Root monitoring system and digital hubs. This innovation facilitates the integration of TetraGraph data with hospital clinical information systems or electronic health records, streamlining the workflow and enhancing patient care efficiency.